Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Cantor Fitzgerald
Julphar
Cerilliant
US Army
Teva
Express Scripts
Harvard Business School
Dow

Generated: June 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 076175

« Back to Dashboard

NDA 076175 describes MEFLOQUINE HYDROCHLORIDE, which is a drug marketed by Barr, Hikma Intl Pharms, Sandoz, Us Army Walter Reed, and West-ward Pharms Int, and is included in five NDAs. It is available from seven suppliers. Additional details are available on the MEFLOQUINE HYDROCHLORIDE profile page.

The generic ingredient in MEFLOQUINE HYDROCHLORIDE is mefloquine hydrochloride. There are six drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the mefloquine hydrochloride profile page.
Summary for 076175
Tradename:MEFLOQUINE HYDROCHLORIDE
Applicant:Sandoz
Ingredient:mefloquine hydrochloride
Patents:0
Therapeutic Class:Antiparasitics
Formulation / Manufacturing:see details
Pharmacology for NDA: 076175
Medical Subject Heading (MeSH) Categories for 076175
Suppliers and Packaging for NDA: 076175
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MEFLOQUINE HYDROCHLORIDE mefloquine hydrochloride TABLET;ORAL 076175 ANDA Physicians Total Care, Inc. 54868-5434 E 54868-5434-0
MEFLOQUINE HYDROCHLORIDE mefloquine hydrochloride TABLET;ORAL 076175 ANDA Physicians Total Care, Inc. 54868-5434 E 54868-5434-1

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength250MG
Approval Date:Feb 20, 2002TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
AstraZeneca
McKinsey
Moodys
Boehringer Ingelheim
Daiichi Sankyo
Cerilliant
Cantor Fitzgerald
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.